Pharma as a sector has been under pressure for a very long time. However, some of the small and mid sized Indian pharma companies which are not hit by pricing pressure of the US generic market and other issues which large pharma companies have been facing keep attracting interest from the analyst. The list is based on upside estimated by the analysts, with the highest potential stock coming on the top of the list.
Cochin Shipyard shares tumble 8% as Q2 profit falls 50% YoY despite revenue growth
Cochin Shipyard shares fell sharply on Wednesday after the company reported a nearly 50% year-on-year decline in Q2 FY27 net profit to Rs 54 crore.
November 11, 2026